4Filed Aug 9, 8:00 PM ET

Procter & Gamble (PG) Research Chief Moses Aguilar Receives RSU Awards

$PG · PROCTER & GAMBLE Co

Research Summary

AI-generated summary of this SEC filing

Updated

Procter & Gamble (PG) Research Chief Moses Aguilar Receives RSU Awards

What Happened Moses Victor Javier Aguilar, Procter & Gamble's Chief Research, Development & Innovation Officer, was granted a series of derivative awards (Restricted Stock Units and dividend-equivalent units) during 2026. The filings show awards on 2026-02-17 (17.669 units), 2026-05-15 (20.665 units), 2026-07-14 (0.315 units) and a primary grant on 2026-08-06 (857 units), for a total of 895.649 RSU-type units. These were awards (code A) with $0.00 acquisition price — i.e., compensation/award units that convert into common stock under plan terms, not open‑market purchases or sales.

Key Details

  • Transaction dates and amounts:
    • 2026-02-17: 17.669 units @ $0.00 (award)
    • 2026-05-15: 20.665 units @ $0.00 (award)
    • 2026-07-14: 0.315 units @ $0.00 (award)
    • 2026-08-06: 857.000 units @ $0.00 (award)
  • Total units reported: 895.649 RSU/dividend-equivalent units (derivative awards).
  • Price paid: $0.00 (these are awards, not purchases).
  • Shares owned after transaction: Not specified in the provided summary of the filing.
  • Filing info: Form 4 filed with accession 0000080424-26-000114 on 2026-08-10 reporting transactions through 2026-08-06 (file date is four days after the latest reported transaction).
  • Relevant footnotes (high level):
    • F1: Includes dividend equivalents settled as RSUs and shares from dividend reinvestment plan.
    • F3/F4/F7: Many units are RSUs tied to the issuer’s retirement program or deferred compensation — contingent rights that generally deliver shares on retirement (or may be deferred/cashed per plan rules).
    • F2/F5/F6: Administrative adjustments and plan-specific pricing/conversion rules apply; some shares may be held by Retirement Plan Trustees.

Context These entries are awards/derivative grants (RSUs and dividend-equivalent units), common forms of executive compensation and retirement benefits, rather than open-market buys or sales. RSUs are contingent rights that typically convert into common stock on vesting or upon retirement/plan distribution; they do not by themselves indicate the insider is buying or selling stock. This filing reports compensation-related awards and should be interpreted as routine grant/plan activity unless additional trading or sales are reported.